Research Paper Volume 13, Issue 19 pp 23361—23375

piRNA-36741 regulates BMP2-mediated osteoblast differentiation via METTL3 controlled m6A modification


Figure 1. piR-36741 and METTL3 expression was upregulated in osteogenic differentiation of BMSCs. BMSCs were treated by 10 mM β-glycerophosphate, 100 nM dexamethasone, and 200 μM ascorbic acid to induce osteogenic differentiation. (AF) The expression of piR-36741 (A), and the mRNA levels of METTL3 (B), RUNX2 (C), COL1A1 (D), OCN (osteocalcin) (E) and OPN (osteopontin) (F) were detected on day 0, 3, 7 and 14. (G) Images of ALP staining (100×). (H) ALP activity was measured on day 0, 7 and 14. (I) Images of Alizarin red S (ARS) staining (100×). (J) Quantitative analysis of ARS accumulation on day 0, 7 and 14. N = 5 in each group. *P < 0.05, **P < 0.01. Each test was independently repeated at least three times.